New Trastuzumab Deruxtecan Trial Outperforms TDM1 in Second-Line Breast Cancer Treatment
1:15
New Trastuzumab Deruxtecan Trial Outperforms TDM1 in Second-Line Breast Cancer Treatment
112 views8 months ago
YouTubeThe Oncology Brief
ESMO25 Highlights: Trastuzumab Deruxtecan in Early HER2+ Breast Cancer | OncoAlert
0:35
ESMO25 Highlights: Trastuzumab Deruxtecan in Early HER2+ Breast Cancer | OncoAlert
259 views11 months ago
YouTubeOncoAlert 360
Trastuzumab-Deruxtecan: A Game-Changer in HER2-Positive Cancers │ Pharmacology
3:45
Trastuzumab-Deruxtecan: A Game-Changer in HER2-Positive Cancers │ Pharmacology
4.1K viewsAug 5, 2024
YouTubePharmacology Insights
Trastuzumab Deruxtecan for Breast Cancer | NEJM
2:06
Trastuzumab Deruxtecan for Breast Cancer | NEJM
36K viewsMar 24, 2022
YouTubeNEJM Group
Trastuzumab deruxtecan (T-DXd) + Pertuzumab FDA Approval in Adv HER2 Breast Cancer: DESTINY-Breast09
22:53
Trastuzumab deruxtecan (T-DXd) + Pertuzumab FDA Approval in Adv HER2 Breast Cancer: DESTINY-Breast09
5.2K views8 months ago
YouTubeOncBrothers: Practice-Changing Cancer Discussions
Understanding Enhertu for HER2-Low & HER2+ Metastatic Breast Cancer
7:53
Understanding Enhertu for HER2-Low & HER2+ Metastatic Breast Cancer
4.5K views7 months ago
YouTubeYerbba – Breast Cancer
T-DXd Expands Treatment Opportunities for HER2-Positive NSCLC
8:23
T-DXd Expands Treatment Opportunities for HER2-Positive NSCLC
671 views2 months ago
YouTubeOncUpdates: Latest Oncology Insights
1:27
Trastuzumab deruxtecan combinations in HER2+ upper gastrointestinal cancers
47 views4 months ago
YouTubeVJOncology
1:03:39
WCLC 2026: What's New in Lung Cancer Treatment? | 13th OncoWisdom Webinar
3 days ago
YouTubeOncoWisdom
1:31
FDA Approves Enhertu for HR+/HER2-low Breast Cancer: Key Trial Results & Insights
2.2K viewsFeb 20, 2025
YouTubeOncologyTube
See more
Static thumbnail place holder